Maintain SCHW at current sizing; no new capital deployment until explicit technical triggers fire
Maintain HOLD at current sizing. The 9/21 reflection is binding: when 9/4 (no chase entries during technical deterioration with distant catalyst) and 9/18 (fundamentals intact, above 200 SMA) collide, technical deterioration should dominate sizing decision including Tier 1, defaulting to Hold with explicit invalidation triggers rather than staged adds. Q3 earnings mid-October is the binary catalyst — a sequential NNA print below ~$40B/month confirms the bear's AUM-deceleration thesis; a continuation of August's $64.8B run-rate validates the bull case.
| Position | Action |
|---|---|
| Current level ($100.35) | No new capital deployment; maintain current sizing |
| Close <$97.70 with volume >15M shares (no intraday recovery) | Trim to Underweight immediately; cascade target $92-$94 |
| Close <$92 | Downgrade to Sell; cascading stops after 200 SMA break |
| Q3 NII prints below $3.2B | Downgrade to Sell; sequential decline confirming peak-NIM |
The Sep 22 crash was a capitulation event driven by sentiment rotation and AI fear, not fundamental deterioration—fundamentals are exceptionally strong with 42% EPS growth, a 12.8x forward P/E (PEG of 0.31), and an 8.2% capital return yield, making the Fed rate hike a direct NIM tailwind and the stock a deep-value opportunity with defined support at the 200 SMA.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 105.54 | bearish |
| 50 SMA | 106.68 | bearish |
| 200 SMA | 97.70 | neutral |
| RSI(14) | 33.41 | bearish |
| MACD | −0.87 | bearish |
| MACD Signal | −0.06 | neutral |
| MACD Histogram | −0.82 | bearish |
| ATR(14) | 2.55 | neutral |
| Bollinger Upper | 112.66 | neutral |
| Bollinger Mid | 107.56 | neutral |
| Bollinger Lower | 102.46 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $106-$108 reclaimed with MACD histogram positive cross AND volume >8M shares
Then: Valid add opportunity — momentum shift confirmed
Fed September 16 25bp hike is a NIM tailwind for Schwab, not a threat
↩ rebuts: “Bear says Fed tightening is bad for rate-sensitive financials”
EV: +14.1% · concedes: One-day ETF outflow of $15B on Sep 21 and record monthly muni ETF outflows are real data points; Bear thesis is technically correct on the technical breakdown (MACD cross, RSI oversold, Bollinger Band breach); AI displacement narrative has some legitimate basis as the bear framing; Deposit-shock concerns in 2024 were real and required $0 buybacks that year
The Sept 22 candle is a high-volume distribution event from a broken uptrend—not capitulation—with momentum still building to the downside, the Fed tailwind already priced in and rejected by price action, the Anthropic partnership non-exclusive and market-rejected, and ETF outflows signaling accelerating fixed-income stress that will pressure AUM and revenue.
EV: $94-92 on 200 SMA break (~$8 downside from $100.35)
→ vs conservative: September 22nd low of 99.30 with 16.9M shares volume is capitulation, not distribution; labeling capitulation as distribution causes investors to miss generational entries
→ vs neutral: Waiting for 106-108 confirmation zone forgoes 6-8% of the move; forward P/E of 12.82x, 20.3% ROE, and 8.2% capital return yield do not require price confirmation for a value argument
→ vs conservative: RSI of 33 is textbook oversold (threshold under 35); labeling this as 'not yet oversold' misreads momentum exhaustion and the 200 SMA still rising from 94 in March confirms underlying strength
| Intraday Range | ~$7.13 (106.43 − 99.30) | bearish |
Support: 97.7 · 92 · 94 | Resistance: 102.46 · 105.54 · 106.68 · 107.56 · 112.66 · 114.53
Sep 22, 2026 produced a violent breakdown candle for SCHW: price gapped down to an intraday low of $99.30 (only $2.65 above the 200 SMA at $97.70) and closed at $100.35, piercing the lower Bollinger Band ($102.46) on roughly 16.9M shares—approximately 2–2.5× the 30-day volume norm. Price simultaneously broke below all three moving averages (10 EMA 105.54, 50 SMA 106.68, 200 SMA 97.70) in a single session, confirming a trend regime shift from bullish to bearish on the short- and medium-term timeframes. MACD has confirmed a bearish crossover with the line (−0.87) below the signal (−0.06) and the histogram expanding negative from +0.10 on Aug 25 to −0.82 on Sep 22, while RSI has flipped from overbought (73–76 in mid-August) to approaching oversold at 33.41. The 200 SMA at $97.70 is the critical last line of structural support; a decisive weekly close below this level would invalidate the multi-month uptrend and open a measured-move target near 92–94. Volatility has spiked with the intraday range of ~$7.13 nearly 3× the ATR of 2.55, warranting wider stop-losses (≥$5–$7) and reduced position sizes until ATR normalizes.
Forward P/E
12.82x
PEG Ratio
~0.9
Capital Return Yield
8.2%
ROE
20.3%
Operating Margin
52.3%
Profit Margin
38.8%
Revenue 2022
$20.76B
Revenue 2023
$18.84B
Revenue 2024
$19.61B
Revenue 2025
$23.92B
Revenue Q2'26 TTM
$26.03B
NII 2022
$10.68B
NII 2023
$9.43B
NII 2024
$9.14B
NII 2025
$11.75B
NII TTM-equivalent
$12.69B
Pretax Income 2022
$9.39B
Pretax Income 2023
$6.38B
Pretax Income 2024
$7.69B
Pretax Income 2025
$11.46B
Net Income 2022
$7.18B
Net Income 2023
$5.07B
Net Income 2024
$5.94B
Net Income 2025
$8.85B
Net Income TTM
$9.72B
EPS 2022
$3.50
EPS 2023
$2.54
EPS 2024
$2.99
EPS 2025
$4.65
EPS TTM
$5.49
Diluted Shares 2022
1.894B
Diluted Shares 2023
1.831B
Diluted Shares 2024
1.834B
Diluted Shares 2025
1.809B
Diluted Shares Q2'26
1.739B
Operating CF 2022
$2.057B
Operating CF 2023
$19.587B
Operating CF 2024
$2.670B
Operating CF 2025
$9.311B
Free CF 2022
$1.086B
Free CF 2023
$18.887B
Free CF 2024
$2.050B
Free CF 2025
$8.763B
CapEx 2022
$0.971B
CapEx 2023
$0.700B
CapEx 2024
$0.620B
CapEx 2025
$0.548B
Buybacks 2022
$4.395B
Buybacks 2023
$3.309B
Buybacks 2024
$0.000
Buybacks 2025
$9.804B
Buybacks Q2'26
$3.054B per quarter
Dividends 2022
$2.110B
Dividends 2023
$2.276B
Dividends 2024
$2.275B
Dividends 2025
$2.329B
Dividends Q2'26
$0.643B per quarter
Total Capital Returned 2022
$6.51B
Total Capital Returned 2023
$5.59B
Total Capital Returned 2024
$2.28B
Total Capital Returned 2025
$12.13B
Interest Paid 2022
$1.355B
Interest Paid 2023
$5.623B
Interest Paid 2024
$6.655B
Interest Paid 2025
$4.557B
Total Assets Q2'26
$517.27B
Equity Q2'26
$50.15B
AOCI Unrealized Losses
$10.6B
52-Week Low
$83.96
52-Week High
$114.53
200-Day SMA
$98.17
Current Price
~$99.80
Strengths
Concerns
The fundamentals section presents a compelling BUY case for Charles Schwab, with the company demonstrating a clear recovery from the 2023 trough: net income surged 74.7% and EPS grew 83.1% from trough to 2025, while Q2'26 TTM EPS of $5.49 reflects continued sequential improvement. The stock trades at a forward P/E of 12.82x with ~42% EPS growth, yielding a PEG ratio of ~0.9, suggesting meaningful undervaluation; combined with an 8.2% capital return yield, the risk-reward profile shows approximately -16% downside to the 52-week low versus +15% upside to the 52-week high. Key risks center on Fed easing impacts on NIM ($300-400M per 25bp cut) and residual AOCI losses of $10.6B, though the 2025 resumption of $9.8B in buybacks and systematic net debt reduction signal strong management confidence in the franchise recovery.
Macro: The Fed's September 16, 2026 rate hike to 3.75%–4.00% (first since 2023, citing resilient activity/spending and 'still elevated' inflation) with 96% Polymarket-implied probability of zero cuts in 2026 reframes the discount-rate story for rate-sensitive financials. US recession odds implied at just 8% by year-end 2026 (down 13 pp week-over-week). Global central bank tilt is tightening or holding, not easing—ECB October at 72% probability of no change; BoE November at 64% probability of 25 bp hike (up 16 pp in a week). No fabricated macro numbers; FRED data unavailable.